In this task, you're given a paragraph and title from the research paper. Your task is to classify whether the given title is suitable or not for the research paper based on the given paragraph. Return "True" if title is proper according to paragraph else "False".
--------
Question: Paragraph: Recent infectious outbreaks highlight the need for platform technologies that can be quickly deployed to develop therapeutics needed to contain the outbreak. We present a simple concept for rapid development of new antimicrobials. The goal was to produce in as little as one week thousands of doses of an intervention for a new pathogen. We tested the feasibility of a system based on antimicrobial synbodies. The system involves creating an array of 100 peptides that have been selected for broad capability to bind and/or kill viruses and bacteria. The peptides are pre-screened for low cell toxicity prior to large scale synthesis. Any pathogen is then assayed on the chip to find peptides that bind or kill it. Peptides are combined in pairs as synbodies and further screened for activity and toxicity. The lead synbody can be quickly produced in large scale, with completion of the entire process in one week. 
 Title: A Simple Platform for the Rapid Development of Antimicrobials

Answer: True


Question: Paragraph: Introduction: Novel immune globulin (IG) products (RI-002, RI-001) have been designed to provide protection against respiratory syncytial virus (RSV) mediated respiratory illness while at the same time meeting the manufacturing requirements established by FDA for antibody supplementation in immunocompromised subjects. Areas covered: This review covers the manufacture and development of both RI-001 and RI-002, including the selection of plasma donors for IG preparation with high-titers of anti-RSV antibody, in vitro, and preclinical data in the cotton rat model S. hispidus, and clinical trials including Phase II and compassionate use studies of RI-001 and a multi-center, pivotal Phase III study of RI-002 in PIDD patients. Expert commentary: The data demonstrate that RI-002 is efficacious in the prevention and treatment of RSV in preclinical normal and immune suppressed animal models and is safe and efficacious in the treatment of patients with various forms of primary immunodeficiency disease (PIDD). This product offers potential advantages over other available IG's for prophylaxis in immunocompromised patients requiring polyclonal immunoglobulin supplementation because of its unique antibody composition. In addition to its enhanced neutralizing anti-RSV activity and its polyclonal IG composition, there is preclinical data to support the use of RI-002 for humoral protection against other respiratory pathogens. ARTICLE HISTORY 
 Title: RI-002, an intravenous immunoglobulin containing high titer neutralizing antibody to RSV and other respiratory viruses for use in primary immunodeficiency disease and other immune compromised populations

Answer: True


Question: Paragraph: Ultraviolet (UV) radiation is a part of the sunlight reaching Earth surface. The UV spectrum of solar radiation is by convention divided into three parts: UV-A: 310-400 nm, UV-B: 280-310 nm and UV-C: less than 280 nm. UV-B is the most energetic component reaching Earth surface because the stratospheric ozone layer effectively absorbs completely wavelengths below 290 nm. UV-B is an increasing threat due to increasing UV-B levels on Earth surface as a consequence of depletion of stratospheric O 3 . In general, the effects of atmospheric UV-B radiation are negative for biological life. Enhanced levels of UV-B radiation can indeed negatively change plant physiological processes, growth and productivity. However, while studying UV-B effects on medicinal plants, some interesting phenomena have been discovered. For example, basil plants respond positively to UV-B radiation by increasing oil yield (Chang et al. J Horticult For 1:27-31, 2009). In other studies medicinal plants show bene fi cial aspects in term of increase in volatile oil yield and secondary metabolite production (Kumari et al. Ecotoxicol Environ Safety ). Medicinal herbs have great market value in India and worldwide. The medicinal value of plants depends upon phenolics, antioxidants and volatile yield. Therefore further UV-B experiments increasing the levels of these compounds are needed. Here we review the effect of UV-B exposure on metabolites, volatiles, and antioxidants potential in medicinal plants. This chapter reports: (1) aspects of the global market for medicinal and aromatic plants in India in order to assist the medicinal plant industry to make informed decisions. (2) The biodiversity loss due to wild harvesting of plants, and as an alternative the cultivation strategy of medicinal plants. (3) Main medicinal plant species having rich antioxidant potential. (4) Main secondary metabolites of plant origin such as phenylpropanoids, terpenes, alkaloids, and volatile oil, and other important metabolites containing high antioxidant level used in human diet and health. (5) UV-B factors that enhance the quality of medicinal plant by increasing the content of secondary bioactive products. (6) Secondary metabolic pathways involving regulation of key enzymes, chalcone synthase, and phenylalanine ammonia lyase. Understanding of UV-B responses on secondary plant metabolites expand new opportunities for plant enriched in medicinal active compounds. 
 Title: Medicinal Plant Active Compounds Produced by UV-B Exposure

Answer:
True